Novartis Fact Sheet, Novartis Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Novartis Fact Sheet    (NVRT)

Here is the latest financial fact sheet of Novartis. For more details, see the Novartis quarterly results and Novartis share price and chart. For a sector overview, read our pharmaceuticals sector report.

NOVARTIS Price History

Price Rs 608.0
Mkt Cap Rs m 203,943
Vol '000 4.1
P/E X 479.2
P/CF X 252.1
EPS (TTM) Rs 1.3
% ch % 1.7
No. of shares m 335.46
% ch week % -0.6
% ch 1-mth % -3.4
% ch 12-mth % -14.6
52 week H/L Rs 789.9/558.0
(As on Oct 18, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

NOVARTIS Financials

No. of Mths
Year Ending
12
Mar-14
12
Mar-15
12
Mar-16
12
Mar-17
12
Mar-18
5-Yr Chart
Click to enlarge
NOVARTIS EQUITY SHARE DATA
High Rs605760982855758 
Low Rs361438556666579 
Sales per share (Unadj.) Rs269.8273.3215.8219.0228.4 
Earnings per share (Unadj.) Rs30.824.862.019.131.7 
Diluted earnings per shareRs2.92.45.91.72.3 
Cash flow per share (Unadj.) Rs32.026.063.120.332.8 
Dividends per share (Unadj.) Rs10.0010.0010.0010.0010.00 
Adj. dividends per shareRs0.950.950.950.890.74 
Dividend yield (eoy) %2.11.71.31.31.5 
Book value per share (Unadj.) Rs300.8313.5373.5307.0297.1 
Adj. book value per shareRs28.729.935.627.421.9 
Shares outstanding (eoy) m31.9631.9631.9629.9624.69 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x1.82.23.63.52.9 
Avg P/E ratio x15.724.212.439.821.1 
P/CF ratio (eoy) x15.123.012.237.520.4 
Price / Book Value ratio x1.61.92.12.52.2 
Dividend payout %32.440.416.152.431.5 
Avg Mkt Cap Rs m15,43319,14724,58022,77916,505 
No. of employees `0001.31.20.80.70.7 
Total wages/salary Rs m1,7422,0001,5671,3931,445 
Avg. sales/employee Rs Th6,663.37,236.09,172.59,736.28,441.3 
Avg. wages/employee Rs Th1,346.11,657.22,083.22,066.82,163.6 
Avg. net profit/employee Rs Th761.4655.42,636.8849.01,173.1 
NOVARTIS INCOME DATA
Net Sales Rs m8,6228,7346,8986,5625,639 
Other income Rs m9511,0768097021,718 
Total revenues Rs m9,5749,8107,7077,2647,357 
Gross profit Rs m-13-39-113259-63 
Depreciation Rs m3740353625 
Interest Rs m322755 
Profit before tax Rs m8999966599171,575 
Minority Interest Rs m00000 
Prior Period Items Rs m3961651700 
Extraordinary Inc (Exp) Rs m0-631,69600 
Tax Rs m310306389345792 
Profit after tax Rs m9857911,983572784 
Gross profit margin %-0.2-0.4-1.63.9-1.1 
Effective tax rate %34.530.759.037.650.3 
Net profit margin %11.49.128.78.713.9 
NOVARTIS BALANCE SHEET DATA
Current assets Rs m10,61010,63412,6379,7319,522 
Current liabilities Rs m2,1222,1072,0451,8303,296 
Net working cap to sales %98.597.6153.6120.4110.4 
Current ratio x5.05.06.25.32.9 
Inventory Days Days4442384937 
Debtors Days Days3335272328 
Net fixed assets Rs m7985695746 
Share capital Rs m160160160141123 
"Free" reserves Rs m9,4529,85911,7769,0567,213 
Net worth Rs m9,61410,02011,9369,1967,336 
Long term debt Rs m00000 
Total assets Rs m12,02112,46114,32611,49911,105 
Interest coverage x334.0475.1314.7128.429.5 
Debt to equity ratio x00000 
Sales to assets ratio x0.70.70.50.60.5 
Return on assets %8.26.413.95.07.6 
Return on equity %10.27.916.66.210.7 
Return on capital %13.511.019.910.122.2 
Exports to sales %0.90.90.900 
Imports to sales %21.814.221.800 
Exports (fob) Rs m79806000 
Imports (cif) Rs m1,8771,2441,50300 
Fx inflow Rs m14414918612961 
Fx outflow Rs m2,3351,6451,8211,7343,630 
Net fx Rs m-2,191-1,497-1,635-1,605-3,570 
NOVARTIS CASH FLOW
From Operations Rs m -46 -596 566 -408 1,610 
From Investments Rs m 222 7,189 -6,305 4,236 687 
From Financial Activity Rs m -378 -377 -386 -3,318 -2,677 
Net Cashflow Rs m -202 6,217 -6,125 510 -380 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 75.0%
Indian inst/Mut Fund 2.0%
FIIs 1.6%
ADR/GDR 0.0%
Free float 21.5%
Shareholders 41,647
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Sandoz House, Shivsagar Estate, Dr. Annie Besant Road, Mumbai-18
E-MAIL girish.tekchandani@novartis.com WEB www.novartis.in
TELEPHONE (022) 2495 8400 FAX (022) 2495 0221
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Sharepro Serv., 13 AB, Samhita Warehousing, Andheri (E), Mumbai-72
AUDITOR Lovelock and Lewes
CHM: C. Snook COMP SEC: Girish Tekchandani YEAR OF INC: 1947 BSE CODE: 500672 FV (Rs): 5 DIV YIELD (%): 0.1

More Pharmaceuticals Company Fact Sheets:   J.B.CHEMICALS  GSK PHARMA  CADILA HEALTHCARE  PFIZER  GLENMARK PHARMA  

Compare NOVARTIS With:   J.B.CHEMICALS  GSK PHARMA  CADILA HEALTHCARE  PFIZER  GLENMARK PHARMA  

Compare NOVARTIS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Views on news

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NOVARTIS

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS